Clinical Trials For Patients With Heart Failure
Have you been diagnosed with heart failure and are out of options? Discover innovative research at the Texas Heart Institute. The Stem Cell Center of the Texas Heart Institute at St. Luke’s Episcopal Hospital in Houston, Texas is actively recruiting patients for FDA-approved clinical studies investigating the use of adult stem cells in treating heart failure.
Heart failure occurs when the heart loses its ability to pump blood efficiently. It usually results from countless heart attacks as a result of blockages in the arteries that feed the heart.
The Stem Cell Center is actively enrolling patients who:
- are on maximal medical therapy.
- have a low ejection fraction.
- have exhausted all conventional therapy (i.e., bypass surgery, stenting and angioplasty).
Many factors are considered before enrolling patients into a research study and enrollment varies according to inclusion criteria.
If you are a patient who has been diagnosed with refractory angina and wishes to be considered for enrollment in a trial, please call us at 1-866-924-STEM(7836), or complete our secure online Patient Information Form.
For more specific information about this study, please visit the study website: Renewstudy.com
If you are a physician and would like to refer a patient for consideration, please contact a study coordinator at the above number or 832-355-9405.